Last checked at 11 Sep 2019 07:00
11 September 2019
IXICO plc
("IXICO" or the "Company")
PDMR share option exercise and TVR
IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that on 10 September 2019, John Hall, SVP Corporate Development, exercised 87,647 share options in the Company resulting in the allotment of new ordinary shares. 50,000 of these shares are allotted at a price of 36.5p and 37,647 of these shares are allotted at a price of 49p.
John Hall is interested in 183,094 Ordinary Shares, representing 0.4 per cent of the enlarged issued share capital of the Company following the exercise of options.
Application has been made to the London Stock Exchange for the admission to trading on AIM of 87,647 new ordinary shares of 1p each ("New Shares") to satisfy the exercise of options. The New Shares are expected to be admitted to trading on AIM on 16 September 2019.
Total voting rights
Application has been made for admission to trading on AIM of 87,647 New Shares. Admission of the New Shares on AIM is expected to become effective at 8.00a.m. on 16 September 2019, following which there will be in total 46,902,294 ordinary shares in the capital of the Company in issue, each carrying equal voting rights.
This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IXICO under the FCA's Disclosure and Transparency Rules.
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| John Hall
| |||
2
| Reason for the notification
| ||||
a)
| Position/status
| SVP Corporate Development | |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| IXICO plc | |||
b)
| LEI
| 2138005M1F59O6HWSA97 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares in IXICO plc | |||
Identification code | GB00BCLY7L40 | ||||
| |||||
b)
| Nature of the transaction
| Exercise of share options | |||
c)
| Price(s) and volume(s) |
|
|
|
|
| Price(s) | Volume(s) |
| ||
| 49p | 37,647 |
| ||
| 36.5p | 50,000 |
| ||
|
|
|
| ||
d)
| Aggregated information | ||||
- Aggregated volume | 87,647 shares | ||||
- Price | 41.9p | ||||
e)
| Date of the transaction
| 10/09/19 | |||
f)
| Place of the transaction
| Outside of a trading venue | |||
IXICO plc | +44 (0) 20 3763 7498 |
Giulio Cerroni, Chief Executive Officer Grant Nash, Chief Financial Officer | |
Cenkos Securities PLC (Nominated adviser and sole broker) | +44 (0) 20 7397 8900 |
Giles Balleny / Max Gould (Corporate Finance) | |
Michael F Johnson / Russell Kerr (Sales) | |
Optimum Strategic Communications | +44 (0) 203 950 9144 |
Mary Clark / Supriya Mathur | |
ixico@optimumcomms.com |